EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, CGEM: Cullinan Therapeutics Inc

19 Dec 25 15:59
LAST:

9.670

CHANGE:
 0.30		OPEN:
10.090		HIGH:
10.140		ASK:
0.000		VOLUME:
454.3K
CHG(%):
3.01		PREV:
9.980		LOW:
9.610		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
19 Dec 2510.13010.1409.6109.6801.87M
18 Dec 259.67010.0909.6009.9801.98M
17 Dec 2510.20010.3709.4809.5901.06M
16 Dec 2510.96011.23010.07510.2201.14M
15 Dec 2511.90012.09010.75510.8201.17M
12 Dec 2512.38012.94011.90011.920955.5K
11 Dec 2512.45013.10012.04012.380891.2K
10 Dec 2512.77012.85012.11012.4601.38M
09 Dec 2512.44012.88011.89512.3601.29M
08 Dec 2510.89012.71010.56012.4402.93M

PROFILE

Name:Cullinan Therapeutics Inc
About:Cullinan Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for autoimmune diseases and cancer in the United States. The company develops zipalertinib, a bioavailable small molecule in Phase 3 trial for the treatment of patients with non-small cell lung cancer; CLN-978, a T cell engager to treat systemic lupus erythematosus and rheumatoid arthritis; and CLN-619, a monoclonal antibody in Phase 1 trial for the treatment of solid tumors and multiple myeloma. Its development products also include CLN-049, a humanized bispecific antibody in Phase 1 trial for the treatment of acute myeloid leukemia (AML) or myelodysplastic syndrome, as well as measurable residual disease positive AML; and CLN-617, a fusion protein in Phase 1 trial for the treatment of solid tumors. It has a collaboration agreement with Adimab, LLC to discover and/or optimize antibodies; and co-development agreement with Taiho Pharmaceutical Co., Ltd to develop zipalertinib. The company was formerly known as Cullinan Oncology, Inc. and changed its name to Cullinan Therapeutics, Inc. in April 2024. Cullinan Therapeutics, Inc. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.
Sector:Healthcare
Industry:Biotechnology
Address:One Main Street, Cambridge, MA, United States, 02142
Website:https://cullinantherapeutics.com
CUSIP:230031106
CIK:0001789972
ISIN:US2300311063
FIGI:BBG00HW2DGQ4

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:9.03 
Forward P/E:-2.43 
PEG Ratio:0.21 
Price to Sales:26.88 
Price to Book:0.95 
Return on Assets:-0.24 
Return on Equity:-0.36 
EPS Ratio:-3.16 
Shares:59.07M 
Market Cap:571.25M 

TECHNICAL INDICATORS

MA5:10.064.0%
MA10:11.1915.7%
MA20:11.0914.7%
MA50:9.264.4%
MA100:8.1019.4%
MA200:8.0819.6%
STO9:2.56 
STO14:2.56 
RSI14:41.81
WPR14:-96.86 
MTM14:-0.52
ROC14:-0.05 
ATR:0.95 
Week High:12.9433.8%
Week Low:9.482.0%
Month High:13.3337.8%
Month Low:8.2319.6%
Year High:13.3337.8%
Year Low:5.6870.2%
Volatility:11.54 

RECENT SPLITS

Date Ratio
31 Aug 20092-1